$3.08
0.279.61%
At close: -
$2.71
-0.37-12.01%
After Hours: 6:49 AM EDT
Comments
Loading...
China SXT Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:SXTC | Benzinga
China SXT Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for China SXT Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for China SXT Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for China SXT Pharmaceuticals (SXTC) stock?
There is no price target for China SXT Pharmaceuticals
What is the most recent analyst rating for China SXT Pharmaceuticals (SXTC)?
There is no analyst for China SXT Pharmaceuticals
When was the last upgrade for China SXT Pharmaceuticals (SXTC)?
There is no last upgrade for China SXT Pharmaceuticals
When was the last downgrade for China SXT Pharmaceuticals (SXTC)?
There is no last downgrade for China SXT Pharmaceuticals.
When is the next analyst rating going to be posted or updated for China SXT Pharmaceuticals (SXTC)?
There is no next analyst rating for China SXT Pharmaceuticals.
Is the Analyst Rating China SXT Pharmaceuticals (SXTC) correct?
There is no next analyst rating for China SXT Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.